Clinical activity of the RET inhibitor pralsetinib (BLU-667) in patients with RET fusion+ solid tumors.

Publication Title

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Authors

Vivek Subbiah
Mini I-Nan Hu
Justin F. Gainor
Aaron Scott Mansfield
Guzman Alonso
Matthew H Taylor, Providence St. Joseph HealthFollow
Viola Weijia Zhu
Pilar Garrido Lopez
Alessio Amatu
Robert C. Doebele
Philippe Alexandre Cassier
Bhumsuk Keam
Martin H. Schuler
Hui Zhang
Corinne Clifford
Michael Palmer
Jennifer Green
Christopher D. Turner
Giuseppe Curigliano

Document Type

Article

Publication Date

5-25-2020

Area of Special Interest

Cancer

Specialty/Research Institute

Earle A. Chiles Research Institute

Specialty/Research Institute

Oncology